A clinical trial evaluating an investigational medication for the treatment of anxiety in adults.
Do you feel excessively worried about routine things?
If so, you may have anxiety and qualify for a clinical research study.
Generalized Anxiety Disorder (GAD) is characterized by persistent and excessive worry about a number of different things. People with GAD may anticipate disaster and may be overly concerned about money, health, family, work, or other issues. Individuals with GAD find it difficult to control their worry. They may worry more than seems warranted about actual events or may expect the worst even when there is no apparent reason for concern. Sometimes just the thought of getting through the day produces anxiety. People with GAD don’t know how to stop the worry cycle and feel it is beyond their control, even though they usually realize that their anxiety is more intense than the situation warrants. All anxiety disorders may relate to a difficulty tolerating uncertainty and therefore many people with GAD try to plan or control situations. Many people believe worry prevents bad things from happening so they view it is risky to give up worry. Many with GAD may avoid situations because they have the disorder or they may not take advantage of opportunities due to their worry (social situations, travel, promotions, etc). Some people can have difficulty carrying out the simplest daily activities when their anxiety is severe.
IPS Research is seeking participants for a clinical trial of an investigational medication for the treatment of Generalized Anxiety Disorder. If you have symptoms of anxiety, you may be a candidate for this clinical trial.
Qualified participants must meet the following requirements:
- Be 18 to 65 years of age
- Have had symptoms of anxiety for the past year
- Anxiety causes distress or impairment in social, occupational, or other areas of life
Qualified participants may receive:
- Study-related care and study drug at no cost
- Compensation for time and travel